Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

2nd Rare CNS and Neurodevelopmental Drug Development Summit

Evvnt Promotion / evvnt
-
28.11.2022 - 30.11.2022  Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 8:00 am - 3:50 pm
 
Temi della conferenza
With further clinical data emerging, drug development for rare CNS and neurodevelopmental disorders is advancing from hypotheticals to real-life clinical results, outcomes, and functional biomarkers; catapulting this critical field forwards to change patients' lives.

The 2nd Rare CNS and Neurodevelopmental Drug Development Summit is the definitive industry-dedicated forum for large pharma, biotech, academia, and patient advocacy groups, paving the way towards symptomatic and successful disease
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/1289306-3?pid=4832

Speakers: Alfica Sehgal, Senior Vice President, Head of Discovery and Translation, CAMP4 Therapeutics and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/1289306-2?pid=4832
Ms. Emily Lincoln
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.00 - USD 5846.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

Swiss Tropical and Public Health InstituteÄrzte der WeltCharité International AcademyAGEM - Arbeitsgemeinschaft Ethnologie und MedizinHilfswerk AustriaEuropean Public Health Association (EUPHA)OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio Sanitario